Mark Rutz
12Patents
5h-index
25Co-inventors
58Inventor score
Filing activity: Oct 30, 2009 → Sep 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8519107B2 | IL-17A antibodies | Chemistry; Metallurgy | 10 | Active |
| US9522957B2 | Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists | Chemistry; Metallurgy | 10 | Active |
| US9255153B2 | Polynucleotides encoding Toll-Like Receptor 3 antagonists | Chemistry; Metallurgy | 10 | Active |
| US9481731B2 | Toll-like receptor 3 antagonists | Chemistry; Metallurgy | 9 | Active |
| US10106605B2 | Compositions and methods for antibodies targeting Epo | Chemistry; Metallurgy | 5 | Active |
| US9365646B2 | Compositions and methods for antibodies targeting EPO | Chemistry; Metallurgy | 3 | Active |
| US9238693B2 | Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies | Chemistry; Metallurgy | 3 | Active |
| US8409567B2 | Toll-like receptor 3 antagonists | Chemistry; Metallurgy | 2 | Active |
| US8460659B2 | Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases | Chemistry; Metallurgy | 2 | Active |
| US8540986B2 | Toll-like receptor 3 antagonists | Chemistry; Metallurgy | 2 | Active |
| US10385127B2 | Compositions and methods for antibodies targeting EPO | Chemistry; Metallurgy | 1 | Active |
| US9932404B2 | Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.